Evolution of the Average Target: Northwest Biotherapeutics, Inc.

Evolution of the Target Price: Northwest Biotherapeutics, Inc.

Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.

30698a39b8cbbbafc4de4a8605e.2i0oNGKIEQKyHFzkMKRP3ztAg5qf7dnbEX5sjbs-LZo.v0VkdgPNJnv7czWOX_E9pVUu1fD3uum-JE0eudpHeKuebm14G-12bP91Kw~3bee7c67d2eceeb76c5cffaa067c0dd5

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+24.29%
+16.73%
+79.89%
+35.55%
+26.41%
+22.58%
-15.4%
+8.66%
-9.11%
Average +21.07%
Weighted average by Cap. +23.56%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1719USD
Average target price
1.000USD
Spread / Average Target
+481.73%
High Price Target
1.000USD
Spread / Highest target
+481.73%
Low Price Target
1.000USD
Spread / Lowest Target
+481.73%

Analyst Consensus Detail

Consensus revision (last 18 months)

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1719USD
Average target price
1.000USD
Spread / Average Target
+481.73%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NWBO Stock
  4. NBYB Stock
  5. Consensus Northwest Biotherapeutics, Inc.